Generon Set to Begin Phase 1 Trial of A-319 in Patients With B-cell Cancers in China
News
China’s regulatory agency has approved the launch of Generon‘s Phase 1 clinical trial to test its immunotherapy candidate, A-319, in patients with acute lymphoblastic leukemia (ALL) and B-cell lymphoma. Approval of ... Read more